Back to ExodusPoint Capital Management, LP ExodusPoint Capital Management, LP

XERSXERS
13 quarters

Position history for ExodusPoint Capital Management, LPExodusPoint Capital Management, LP's holdings in XERIS BIOPHARMA HOLDINGS INC

No. ExodusPoint Capital Management exited its XERS (Xeris Biopharma Holdings) position in Q2 2026. Its Q1 2026 13F listed 25,685 shares worth $148,973. ExodusPoint Capital Management already held XERS in its Q4 2021 13F, the earliest on record, and held it in 8 quarterly 13F filings.

Final Value

$0

Final Shares

0

Total Value Change

-$118,000

Total Shares Change

-40,394

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Exited
0
-100.0%
$00.0%$7.92
0
2026-Q1
New
25,685
-
$148,9730.0%$5.94
31
2025-Q4
Exited
0
-100.0%
$00.0%$7.31
0
2025-Q3
New
86,920
-
$707,5290.0%$8.08
34
2024-Q4
Exited
0
-100.0%
$00.0%$3.38
0
2024-Q3
New
84,740
-
$242,0000.0%$2.87
32
2023-Q4
Exited
0
-100.0%
$00.0%$2.35
0
2023-Q3
New
185,221
-
$345,0000.0%$1.86
33
2022-Q4
Exited
0
-100.0%
$00.0%$1.33
0
2022-Q3
Decreased
20,528
-63.9%
$32,0000.0%$1.59
0
2022-Q2
Decreased
56,794
-88.9%
$87,0000.0%$1.48
0
2022-Q1
Increased
509,958
+1162.5%
$1.3M0.0%$2.63
41
2021-Q4
New
40,394
-
$118,0000.0%$2.43
30

Other major holders of XERS: BlackRock, Inc., VANGUARD GROUP INC

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used